Liberum
MENU

News

Liberum appointed Joint Corporate Broker to MedicX Fund Limited

10 May 2018 | Joint Corporate Broker

Medicxfund

Liberum is pleased to announce its appointment as Joint Corporate Broker to MedicX Fund Limited.

MedicX is a specialist primary healthcare REIT which invests in modern, purpose-built primary healthcare properties in the UK & Republic of Ireland. The Company has a portfolio of 151 completed properties with an average value of £4.4m.

MedicX selectively buys high quality dominant assets or forward-funds new schemes under framework agreements with a range of experienced developers in both the UK and the Republic of Ireland.

The fund is listed on the Premium Segment of the Main Market and has a market capitalisation of c.£346m.

Liberum has been appointed as Joint Corporate Broker alongside Canaccord, with immediate effect.

Liberum Team

Board – David Parsons
Investment Banking – Richard Crawley, Jamie Richards, Laura Hamilton, William Hall

Sales – John Mozley
Research – David Brockton
Corporate Access – Lucy Williams

Press Enquiries: Redleaf Polhill

Emailliberum@redleafpr.com

Call: +44 (0)20 7382 4747

Follow Liberum

Twitter@LiberumToday
LinkedInLiberum

 

Liberum acts as Sole Corporate Broker to AEW UK REIT plc.

03 May 2018 | Sole Corporate Broker

AEW

AEW UK REIT plc (AEWU) is a real estate investment trust listed on the premium listing segment of the Official List and traded on the Main Market. It invests in a diversified portfolio of small, high yielding commercial properties across the UK. AEWU listed in May 2015 and has raised more capital six times since.

AEWUK has a highly experienced investment manager, AEW UK Investment Management LLP, which is part of AEW Global, one of the world’s largest real estate managers with €57.7bn of assets worldwide.

Liberum pitched for the brokership recently and now acts as Sole Corporate Broker and will act as Sole Bookrunner in connection with any placings.

Liberum Team

Investment Banking - Gillian Martin, Jamie Richards, Kane Collings

Research - Conor Finn, David Brockton

Sales - Andrew Davies, Anastasia Mikhailova, Jack Kershaw, John Mozley

Press Enquiries: Redleaf Polhill

Emailliberum@redleafpr.com

Call: +44 (0)20 7382 4747

Follow Liberum

Twitter@LiberumToday
LinkedInLiberum

 

Liberum appointed Joint Corporate Broker to Crest Nicholson

02 May 2018 |

Crest -1 (1)

Liberum is pleased to announce its appointment as Joint Corporate Broker to Crest Nicholson.

Crest Nicholson is a leading residential developer operating in the Southern half of England with an emphasis on creating well designed homes in sustainable communities. The Group has a wide product range, varying from homes for first time buyers through to large family homes, and includes a mixture of houses, apartments and supporting commercial premises as part of its larger developments.

The Group, which was established over 50 years ago in 1963, has a history of 39 years on the Official List and trading on the London Stock Exchange’s Main Market between 1968 and 2007. The Group re-listed on the London Stock Exchange in 2013.

Crest Nicholson has a market capitalization of £1.2bn and is a constituent of the FTSE 250.

Liberum has been appointed as Joint Corporate Broker alongside Barclays with immediate effect.

Liberum Team

Board - David Parsons

Sales – Julian Collett

Research – Charlie Campbell

Investment Banking – Neil Patel, Richard Bootle, Louis Davies

Corporate Access – Lynsey Cox

Press Enquiries: Redleaf Polhill

Emailliberum@redleafpr.com

Call: +44 (0)20 7382 4747

Follow Liberum

Twitter@LiberumToday
LinkedInLiberum

Liberum appointed as Sole Broker and Nomad to Ilika plc

26 April 2018 | Nomad and Sole Broker

Ilika

Ilika isa pioneer in material innovation and solid state battery technology. Ilika iscommercialising its world-class Stereax™ solid-state battery technology built around proprietary materials and processing IP capable of producing lighter, safer, batteries that charge up to 6x faster, last 4x longer, and have over 2x the energy density of the highest performance lithium ion incumbents. Also, due to its capacity to hold charge at very small scale, perform over a wide range of temperatures (-40°C to 150°C) and perform in extreme environmental conditions. Stereax™ is a perfect power source for small sensors and beacons that connect to the Industrial Internet of Things (IIoT).

Commercialisation partners include large blue-chip multinational companies in the energy and electronics sectors such as Toyota, Shell, Murata, Applied Materials, Toshiba, NXP, Sigma Aldrich, Johnson Matthey and CeramTec.

Ilika has been listed on AIM since 2010 and has a market capitalisation of c.£17m.

Liberum Team

Neil Elliot, Investment Banking Director

Jill Li, Investment Banking Assistant Director

Oliver Baxendale, Small & Mid Cap Sales

Adam Collins, Research

Follow Liberum:

Twitter: @LiberumToday

LinkedIn: Liberum

Liberum acts as Sole Bookrunner on Asiamet’s £7.2m fundraise

26 March 2018 | Joint Broker

 Ar _498x 280

Liberum is pleased to announce that it acted as sole bookrunner in relation to a placing for Asiamet Resources Limited (“Asiamet”), raising £7.2 million (c.US$10 million) of gross proceeds for the Company at 11p per share.

Asiamet is a dynamic junior company focussed on the exploration and development of its portfolio of large copper-gold deposits on the Indonesian islands of Kalimantan and Sumatra, adjacent to the key growth markets in Asia.
Gross proceeds of the Placing and existing cash reserves of c.US$2.0m are expected to be utilised as follows:
• US$4.7 million for increasing ownership at its Beutong copper porphyry project (from 40% to 80%) and accelerating drilling at the property including metallurgical programmes;
• US$2.5 million for regional exploration on the KSK Contract of Work Area;
• US$3.3 million to commence optimisation and early works in relation to the Company’s BKM copper project and completion of the Bankable Feasibility Study; and
• US$ 1.5 million for general working capital purposes including the costs of the Placing.
The Company has been listed on AIM since 2006 and now has a market capitalisation of c.£120m.

Liberum Team

Investment Banking - Neil Elliot, Clayton Bush and Kane Collings

Sales - Julian Collett and Oliver Baxendale

Research - Richard Knights

Corporate Access - Lynsey Cox

Follow Liberum:

Twitter: @LiberumToday

LinkedIn: Liberum

 

Liberum is pleased to announce its appointment as Joint Broker to U+I Group PLC

13 March 2018 | Joint Broker
Liberum appointed Joint Broker to  U+I Group

U+I is a specialist regeneration and property developer recognised for creative vision and entrepreneurial flair. It has a £6 billion portfolio of complex, mixed-use, community-focused regeneration projects primarily in the London, Manchester and Dublin city regions, and a £211m investment portfolio.

The company operates by repositioning undervalued parts of towns and cities into new places that deliver social and economic value to a wide range of stakeholders. Their expertise in asset management, regeneration and trading allows them to unlock this value.

U+I is listed on the Premium segment of the Main Market and has a market capitalisation of c.£250m.

Liberum has been appointed as Joint Corporate Broker alongside Peel Hunt, with immediate effect.

Liberum Team

Board – David Parsons

Investment Banking – Richard Crawley, Jamie Richards, Kane Collings, Laura Hamilton

Sales – John Mozley

Research – David Brockton

Corporate Access – Lynsey Cox

Follow Liberum

Twitter: @LiberumToday
LinkedIn: Liberum